FERMENTA BIOTECH
Back to Balance Sheet
|
FERMENTA BIOTECH Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹29 Cr | ₹77 Cr | ₹97 Cr | ₹154 Cr | ₹131 Cr |
What is the latest Total Non-Current Liabilities ratio of FERMENTA BIOTECH ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2025 | ₹29 Cr |
| Mar2024 | ₹77 Cr |
| Mar2023 | ₹97 Cr |
| Mar2022 | ₹154 Cr |
| Mar2021 | ₹131 Cr |
How is Total Non-Current Liabilities of FERMENTA BIOTECH Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹29 Cr | -62.03 | |
| Mar2024 | ₹77 Cr | -20.94 | |
| Mar2023 | ₹97 Cr | -36.76 | |
| Mar2022 | ₹154 Cr | 17.22 | |
| Mar2021 | ₹131 Cr | - | |
Compare Total Non-Current Liabilities of peers of FERMENTA BIOTECH
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| FERMENTA BIOTECH | ₹1,303.0 Cr | -1.7% | 39.2% | 12.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹470,786.0 Cr | 0.8% | 7.3% | 15.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹194,590.0 Cr | 1.9% | 8.2% | 6.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹191,658.0 Cr | 0.6% | 12.6% | 43.9% | Stock Analytics | |
| CIPLA | ₹115,728.0 Cr | 0.2% | 6.3% | -4.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,708.0 Cr | -1.8% | -3.5% | -3.4% | Stock Analytics | |
FERMENTA BIOTECH Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| FERMENTA BIOTECH | -1.7% |
39.2% |
12.2% |
| SENSEX | 0.1% |
0.7% |
-6.6% |
You may also like the below Video Courses